Dermatologic implications of immunological unresponsiveness.
D000361:Agammaglobulinemia / Q000151:congenital; D000818:Animals; D000937:Antigen-Antibody Reactions; D000941:Antigens / Q000008:administration & dosage; D000961:Antilymphocyte Serum / Q000008:administration & dosage; D004361:Drug Tolerance; D006087:Graft vs Host Reaction; D006689:Hodgkin Disease / Q000276:immunology; D006801:Humans; D006968:Hypersensitivity, Delayed; D007108:Immune Tolerance; D007110:Immunity, Active; D007136:Immunoglobulins; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D007279:Injections, Subcutaneous; D051379:Mice; D009747:Nutritional Physiological Phenomena; D012507:Sarcoidosis / Q000276:immunology; D012867:Skin / Q000276:immunology*; D012882:Skin Tests; D013950:Thymus Gland / Q000002:abnormalities; D014181:Transplantation Immunology
D000941:Antigens; D000961:Antilymphocyte Serum; D007136:Immunoglobulins; D007166:Immunosuppressive Agents